Literature DB >> 7548731

Acrolein mercapturates: synthesis, characterization, and assessment of their role in the bladder toxicity of cyclophosphamide.

K Ramu1, L H Fraiser, B Mamiya, T Ahmed, J P Kehrer.   

Abstract

Acrolein is the metabolite of cyclophosphamide (CP) believed to be involved in the bladder toxicity associated with this anticancer drug. The mechanism by which this extremely reactive intermediate is delivered to the bladder is not known. Glutathione (GSH) readily conjugates with acrolein, and the acrolein mercapturate S-(3-hydroxypropyl)-N-acetylcysteine (3-hydroxy-PrMCA) has been found in the urine of animals and man given CP. The objectives of this study were to prepare and characterize synthetic standards of the GSH acrolein adduct (3-oxopropyl)glutathione (3-oxoPrGSH), the acrolein mercapturates S-(3-oxopropyl)-N-acetylcysteine (3-oxoPrMCA) and 3-hydroxyPrMCA, and the S-oxidation product of 3-oxoPrMCA (3-oxoPrMCA S-oxide). In addition, the release of acrolein from, and the bladder toxicity of, these conjugates was determined. 3-OxoPrGSH and 3-oxoPrMCA were prepared with a 99% yield by condensing acrolein with GSH and N-acetylcysteine, respectively. 3-HydroxyPrMCA was prepared with a 63% yield by refluxing 3-chloropropanol and N-acetylcysteine in a basic medium. Oxidation of 3-oxoPrMCA with H2O2 was used to prepare 3-oxoPrMCA S-oxide. By decreasing the reaction time to 1 h, and adjusting the ratio of 3-oxoPrMCA to H2O2, the yield of 3-oxoPrMCA S-oxide was increased to 96%. The anhydrous aldehyde, 3-oxoPrMCA, afforded characteristic aldehydic proton resonances (1H NMR) in deuterated dimethyl sulfoxide. New resonances were observed in deuterated water, indicating a 75% hydration of the aldehyde to the corresponding geminal diol. This phenomenon was enhanced with 3-oxoPrMCA S-oxide where approximately 100% hydration of the aldehyde to the corresponding geminal diol was observed. When incubated at 25 degrees C in 100 mM potassium phosphate buffer containing 1 M KCl, pH 8.0, 3-oxoPrMCA released approximately 6% and 3-oxoPrMCA S-oxide released approximately 16-18% of the theoretical maximum yield of acrolein after 30 min, as indicated by an increase in absorbance at 210 nm and confirmed by trapping this aldehyde as a semicarbazone. There was less than a 2% yield of acrolein from 3-hydroxyPrMCA or 3-oxoPrGSH under similar conditions. At pH 7.4 the release of acrolein from 3-oxoPrMCA and 3-oxoPrMCA S-oxide was decreased by 50%. An assay where aldehydes are reacted with m-aminophenol in acid media produced fluorescence consistent with 72%, 46%, 23%, and 1% yields of acrolein from 3-oxoPrMCA S-oxide, 3-oxoPrMCA, 3-oxoPrGSH, and 3-hydroxyPrMCA, respectively.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548731     DOI: 10.1021/tx00046a005

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  10 in total

1.  Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart.

Authors:  S Srivastava; A Chandra; L F Wang; W E Seifert; B B DaGue; N H Ansari; S K Srivastava; A Bhatnagar
Journal:  J Biol Chem       Date:  1998-05-01       Impact factor: 5.157

Review 2.  Evidence-Based Practice Recommendations for Hydration in Children and Adolescents With Cancer Receiving Intravenous Cyclophosphamide.

Authors:  Deborah Robinson; Ginny Schulz; Rachel Langley; Kevin Donze; Kari Winchester; Cheryl Rodgers
Journal:  J Pediatr Oncol Nurs       Date:  2014-05-05       Impact factor: 1.636

3.  Rapid detection and identification of N-acetyl-L-cysteine thioethers using constant neutral loss and theoretical multiple reaction monitoring combined with enhanced product-ion scans on a linear ion trap mass spectrometer.

Authors:  Karoline Scholz; Wolfgang Dekant; Wolfgang Völkel; Axel Pähler
Journal:  J Am Soc Mass Spectrom       Date:  2005-10-24       Impact factor: 3.109

4.  Murine hepatic aldehyde dehydrogenase 1a1 is a major contributor to oxidation of aldehydes formed by lipid peroxidation.

Authors:  Ngome L Makia; Pasano Bojang; K Cameron Falkner; Daniel J Conklin; Russell A Prough
Journal:  Chem Biol Interact       Date:  2011-01-20       Impact factor: 5.192

5.  Spectroscopic characterization of interstrand carbinolamine cross-links formed in the 5'-CpG-3' sequence by the acrolein-derived gamma-OH-1,N2-propano-2'-deoxyguanosine DNA adduct.

Authors:  Young-Jin Cho; Hye-Young Kim; Hai Huang; Alvira Slutsky; Irina G Minko; Hao Wang; Lubomir V Nechev; Ivan D Kozekov; Albena Kozekova; Pamela Tamura; Jaison Jacob; Markus Voehler; Thomas M Harris; R Stephen Lloyd; Carmelo J Rizzo; Michael P Stone
Journal:  J Am Chem Soc       Date:  2005-12-21       Impact factor: 15.419

6.  Protein modification by acrolein: formation and stability of cysteine adducts.

Authors:  Jian Cai; Aruni Bhatnagar; William M Pierce
Journal:  Chem Res Toxicol       Date:  2009-04       Impact factor: 3.739

7.  Acacia Senegal gum exudate offers protection against cyclophosphamide-induced urinary bladder cytotoxicity.

Authors:  Abdulaziz A Al-Yahya; Abdulhakeem A Al-Majed; Ali M Gado; Mohammad H Daba; Othman A Al-Shabanah; Adel R A Abd-Allah
Journal:  Oxid Med Cell Longev       Date:  2009 Sep-Oct       Impact factor: 6.543

8.  Delayed toxicity of cyclophosphamide on the bladder of DBA/2 and C57BL/6 female mouse.

Authors:  Elsa Anton
Journal:  Int J Exp Pathol       Date:  2002-02       Impact factor: 1.925

9.  Kinetics and mechanism of protein tyrosine phosphatase 1B inactivation by acrolein.

Authors:  Derrick R Seiner; Jason N LaButti; Kent S Gates
Journal:  Chem Res Toxicol       Date:  2007-07-27       Impact factor: 3.739

10.  The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Chakradhara Rao S Uppugunduri; Flavia Storelli; Vid Mlakar; Patricia Huezo-Diaz Curtis; Aziz Rezgui; Yves Théorêt; Denis Marino; Fabienne Doffey-Lazeyras; Yves Chalandon; Peter Bader; Youssef Daali; Henrique Bittencourt; Maja Krajinovic; Marc Ansari
Journal:  Front Pharmacol       Date:  2017-07-11       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.